1. The Emerging Roles and Therapeutic Implications of Epigenetic Modifications in Ovarian Cancer
    Yu Wang et al, 2022, Frontiers in Endocrinology CrossRef
  2. LSINCT5: A Novel lncRNA in Cancers
    Xinyan Qiu et al, 2023, Current Medicinal Chemistry CrossRef
  3. LncRNA-MSC-AS1 inhibits the ovarian cancer progression by targeting miR-425-5p
    Yinling Zhao et al, 2021, Journal of Ovarian Research CrossRef
  4. Determination of Potential Therapeutic Targets and Prognostic Markers of Ovarian Cancer by Bioinformatics Analysis
    Jing Zhang et al, 2021, BioMed Research International CrossRef
  5. A hybrid approach to assess the structural impact of long noncoding RNA mutations uncovers key NEAT1 interactions in colorectal cancer
    Efe Aydın et al, 2023, IUBMB Life CrossRef
  6. Long non-coding RNA MYU promotes ovarian cancer cell proliferation by sponging miR-6827-5p and upregulating HMGA1
    Shaoyu Wang et al, 2023, Pathology and Oncology Research CrossRef
  7. Focus on PD-1/PD-L1 as a Therapeutic Target in Ovarian Cancer
    Adrian Dumitru et al, 2022, International Journal of Molecular Sciences CrossRef

  8. lncRNA LSINCT5 Regulates miR-20a-5p/XIAP to Inhibit the Growth and Metastasis of Osteosarcoma Cells


    Shi-An Liao et al, 2020, OncoTargets and Therapy CrossRef